Jan 08, 2013

Chugai and Debiopharm Group^TMAnnounce an Exclusive License
Agreement for Anti-Cancer Agent, FF284 (Debio 1347)

Home
About Chugai
News
Chugai and Debiopharm GroupTMAnnounce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347)

You are now moving to an external website.